Broad and Cross-Clade CD4(+) T-Cell Responses Elicited by a DNA Vaccine Encoding Highly Conserved and Promiscuous HIV-1 M-Group Consensus Peptides


Autoria(s): Almeida, Rafael Ribeiro; Rosa, Daniela Santoro; Ribeiro, Susan Pereira; Santana, Vinicius Canato; Kallas, Esper Georges; Sidney, John; Sette, Alessandro; Kalil, Jorge; Cunha-Neto, Edecio
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

21/10/2013

21/10/2013

2012

Resumo

T-cell based vaccine approaches have emerged to counteract HIV-1/AIDS. Broad, polyfunctional and cytotoxic CD4(+) T-cell responses have been associated with control of HIV-1 replication, which supports the inclusion of CD4(+) T-cell epitopes in vaccines. A successful HIV-1 vaccine should also be designed to overcome viral genetic diversity and be able to confer immunity in a high proportion of immunized individuals from a diverse HLA-bearing population. In this study, we rationally designed a multiepitopic DNA vaccine in order to elicit broad and cross-clade CD4(+) T-cell responses against highly conserved and promiscuous peptides from the HIV-1 M-group consensus sequence. We identified 27 conserved, multiple HLA-DR-binding peptides in the HIV-1 M-group consensus sequences of Gag, Pol, Nef, Vif, Vpr, Rev and Vpu using the TEPITOPE algorithm. The peptides bound in vitro to an average of 12 out of the 17 tested HLA-DR molecules and also to several molecules such as HLA-DP, -DQ and murine IA(b) and IA(d). Sixteen out of the 27 peptides were recognized by PBMC from patients infected with different HIV-1 variants and 72% of such patients recognized at least 1 peptide. Immunization with a DNA vaccine (HIVBr27) encoding the identified peptides elicited IFN-gamma secretion against 11 out of the 27 peptides in BALB/c mice; CD4(+) and CD8(+) T-cell proliferation was observed against 8 and 6 peptides, respectively. HIVBr27 immunization elicited cross-clade T-cell responses against several HIV-1 peptide variants. Polyfunctional CD4(+) and CD8(+) T cells, able to simultaneously proliferate and produce IFN-gamma and TNF-alpha, were also observed. This vaccine concept may cope with HIV-1 genetic diversity as well as provide increased population coverage, which are desirable features for an efficacious strategy against HIV-1/AIDS.

Brazilian National Research Council (CNPq) [420166/2005-0]

Brazilian National Research Council (CNPq)

Sao Paulo State Research Funding Agency (FAPESP) [2004/15856-9, 2006/50096-0, 2008/57881-0]

Sao Paulo State Research Funding Agency (FAPESP)

Brazilian Program for STD and AIDS, Ministry of Health

Brazilian Program for STD and AIDS, Ministry of Health [914/BRA/3014-UNESCO/Kallas]

Sao Paulo City Health Department [2004-0.168.922-7/Kallas]

Sao Paulo City Health Department

Brazilian Council for Scientific and Technological Development - CNPq productivity awards

Brazilian Council for Scientific and Technological Development CNPq productivity awards

Identificador

PLOS ONE, SAN FRANCISCO, v. 7, n. 9, supl. 4, Part 1-2, pp. 281-284, SEP 18, 2012

1932-6203

http://www.producao.usp.br/handle/BDPI/35186

10.1371/journal.pone.0045267

http://dx.doi.org/10.1371/journal.pone.0045267

Idioma(s)

eng

Publicador

PUBLIC LIBRARY SCIENCE

SAN FRANCISCO

Relação

PLOS ONE

Direitos

openAccess

Copyright PUBLIC LIBRARY SCIENCE

Palavras-Chave #IMMUNODEFICIENCY-VIRUS TYPE-1 #RHESUS-MONKEYS #IMMUNE-RESPONSES #DISCORDANT ASSOCIATIONS #LYMPHOCYTE RESPONSES #SIV REPLICATION #PATHOGENIC SIV #VIRAL LOAD #EPITOPES #INFECTION #MULTIDISCIPLINARY SCIENCES
Tipo

article

original article

publishedVersion